Clinical Trial Update: A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase II study of combining hydroxychloroquine and sirolimus for soft tissue sarcoma was terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Shin Kong Wu Ho-Su Memorial Hospital | Conditions: Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2015-11-03